Ondansetron HCL 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ4NU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,229
Award facts
- Contract value 100% obligated
- $18,229.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,229.36 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count) on December 1, 2025, with completion targeted for December 2, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same city. This award represents a single delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026.
Ondansetron, an antiemetic medication commonly used to prevent nausea and vomiting in medical settings including military healthcare, supports the Defense Logistics Agency's medical supply chain operations. AmerisourceBergen Drug Corp maintains an extensive portfolio of federal pharmaceutical contracts with the DLA, supplying a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capacity to compete and win awards across the federal pharmaceutical procurement landscape underscores its critical role as a prime vendor for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FZ4NU?
SPE2DR26FZ4NU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FZ4NU worth?
The government has obligated $18,229 on SPE2DR26FZ4NU.
Is contract SPE2DR26FZ4NU an order under another contract?
Yes. SPE2DR26FZ4NU is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4NU competed?
The extent of competition for SPE2DR26FZ4NU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award